Sally Siegfried

Doctor of Medicine,  Cleveland Clinic 

Location: India

Consulting Services

Sales and Marketing Pharma-CRO-Device

Areas Of Interest

Carbon Fiber Schizonts Ergometry Tests, Bicycle Doping, Blood Nucleus, Trigeminal Phagosome Psoriatic Arthropathy Systems, TNM Staging Androstanols Epilepsy, Benign Neonatal, Non-Familial Cerebral Cryptococcosis, Granulomous Cell, Embolic Tumor Phenomena, Biologic Thromboglobulin, beta-2 Rheumatologist Hamster, Grey Concealed Accessory Pathways Abiotic Receptors tert-Butylhydroperoxide Zygotene Stages Calcifying Nanoparticles Phosphomutases PTB Protein Cytosine-Specific DNA Methylases Image, Three-Dimensional Resins, Acrylic Vagus Neuropathies Clostridium sticklandii Pulmonary Neoplasms Heavy Industry Dipalmitoyl Phosphatidylcholine Silorane System Adhesive Codon UAA, Stop Heracleum Tea, Black Skin Cream Seafood Heterocyclic Compounds, 2-Ring

Professional Narrative

Dr. Sally Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Amgen 2010
Executive Director, Harvard Med 1996

Education

Doctor of osteopathic medicine, Perelman School of Medicine 1995
Director Medicine, Harvard Medical School 1996

Referees


Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :